News

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The issuer is solely responsible for the content of this announcement.
The FDA is phasing out animal testing for monoclonal antibody therapies, embracing AI and human-based models. Read more here.
Fujitsu Limited and AI solutions provider Headwaters Co., Ltd. today announced the successful completion of field trials ...
The obvious result of the legal shootout between the U.S. Food & Drug Administration (FDA) and clinical laboratory trade associations, the American Clinical Laboratory Association and the Association ...